Gardner Lewis Asset Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Gardner Lewis Asset Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,428,884	Closed	-$14.2M	–	93
2023 Q1	$14.2M	Buy	+1,428,884	New	+$14.2M	4.9%	1

Gardner Lewis Asset Management's APEN Position: Q2 2023 in Review

Gardner Lewis Asset Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,428,884 shares — an estimated $14.2M sold.

Gardner Lewis Asset Management first reported a position in APEN in Q1 2023 and held it in 1 quarter. The position peaked at $14.2M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Gardner Lewis Asset Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Gardner Lewis Asset Management sold 1,428,884 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $14.2M.
Gardner Lewis Asset Management first reported a position in Apollo Endosurgery, Inc. in Q1 2023 and held it in 1 quarter.
Gardner Lewis Asset Management's Apollo Endosurgery, Inc. position peaked at $14.2M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.